Considerations, barriers and enablers of deprescribing among healthcare professionals in Ogun State, Southwest, Nigeria: a cross-sectional survey DOI Creative Commons
Sule A. Saka,

Tolulope Ruth Osineye

BMC Health Services Research, Journal Year: 2024, Volume and Issue: 24(1)

Published: May 24, 2024

Abstract Background Deprescribing is a clinical intervention aimed at managing polypharmacy and improving older adults’ health outcomes. However, evidence suggests that healthcare professionals (HCPs) may face challenges in implementing the intervention. This study to explore considerations, barriers enablers of deprescribing among HCPs Southwest Nigeria. Methods A quantitative cross-sectional survey was carried out consecutively sampled including physicians, pharmacists nurses two public tertiary hospitals Ogun State, Southwest, structured 43-item self-administered questionnaire used participants’ sociodemographics, HCPs’ experience, adults. The data were summarised using descriptive statistics frequency percentage. Kruskal–Wallis test determine differences perceptions groups on Likert scale. p -value < 0.05 considered significant. Results Overall, 453 copies analysed. Of participants 204 (45.0%) within age group 20–30 years; 173 (38.2%) claimed adults occasionally requested their medications. majority (417; 92.1%) patients’ quality life be very important deprescribing; 423 (93.4%) opined having care goal known members HCP team an enabler for while 308 (68.0%) disagreed or strongly lack incentives remuneration de-prescribe barrier deprescribing. There significant difference across professional assertion pressure from pharmaceutical companies ( = 0.037). Conclusions this had various considerations medication life. Having every involved patient not necessarily need regulations policies support identified reduce effective process.

Language: Английский

Aligning Medications With What Matters Most: Conversations Between Pharmacists, People With Dementia, and Care Partners DOI Open Access
Ariel R. Green, Rosalphie Quiles, Andrea E. Daddato

et al.

Journal of the American Geriatrics Society, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 3, 2025

Successful deprescribing for people with dementia (PWD) depends on communication about medication-related priorities between PWD, care partners and clinicians. The objective of this study was to gain in-depth knowledge how elicitation PWD partner during a intervention shaped discussions pharmacists medications. Qualitative analysis audio-recorded interactions patient-care dyads in pilot pharmacist-led primary care. Patients ≥ 65 years taking 7 medications were recruited from an integrated delivery system Colorado community-based medical practice Maryland. content used analyze 82 transcripts encounters 55 dyads. mean (SD) age 81 (8.1) years; 45% women, 33% Black, 15% Hispanic. took average 13 (±5.3) at baseline. Care 66 (13) most spouses/partners the PWD. Content identified five themes: (1) Reducing treatment burden; (2) Alleviating burdensome symptoms; (3) Maintaining cognition function; (4) Discussion tradeoffs; (5) Challenges deprescribing. After eliciting patient priorities, recommended both prescribing. Findings secondary suggest can support goal-concordant These results inform development interventions optimize population.

Language: Английский

Citations

1
Multicomponent intervention to tailor prescriptions to patients with dementia in an intermediate care hospital: pre-post quasi experimental study DOI Creative Commons
Matilde Barneto-Soto, Joan Espaulella‐Panicot, Emma Puigoriol‐Juvanteny

et al.

BMC Geriatrics, Journal Year: 2025, Volume and Issue: 25(1)

Published: Feb. 27, 2025

In persons with dementia, polypharmacy may be discordant the goals of care. It is necessary to design interventions that align treatment regimens patient's situation, prognosis and preferences. The objectives this study conducted at an intermediate care were to: i) identify inappropriate prescribing per main goal; ii) compare pharmacotherapy data pre post a medication review based on degree cognitive impairment; iii) assess implementation proposed recommendations three months after discharge. Pre-post quasi-experimental study. Patients dementia discharged from hospital between November 2021 April 2022. Demographic, clinical evaluated admission. Medication reviews interviews caregivers pharmacologic therapies overall At discharge, information was shared primary team in discharge summary. Follow up evaluate during performed months. Of 97 patients included, 94.8% had least one inappropriately prescribed medication. mean number chronic medications taken patient decreased by 29.6%, 8.05(SD 3.5) 5.67(SD 2.7) (p < 0.001); anticholinergic burden 18.6%, 1.59(SD 1.0) 1.29(SD 0.9) therapeutic complexity 28.4%, 29.23(SD 13.8) 20.94(SD 11.3) 0.001). 3 90.0%. Admission provides ideal setting for multicomponent intervention, tailoring prescriptions preferences, improving parameters related side effects, ensuring are maintained over medium term.

Language: Английский

Citations

0
Potentially Inappropriate Prescriptionss in End-of-Life Cancer Patients in Home-Based Hospice Care DOI Creative Commons
Junyong Lee, Chung-Woo Lee, Hwa Sun Kim

et al.

Journal of Pain and Symptom Management, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Polypharmacy and inappropriate prescribing are prevalent among end-of-life cancer patients, potentially compromising symptom management quality of life. Limited data available on medications (PIMs) omissions (PPOs) opioid in South Korea, particularly home-based hospice care settings. This study aimed to evaluate the prevalence PIMs PPOs advanced patients referred identify factors associated with these issues. A retrospective observational included 102 a single center's between November 2022 2023. were assessed using STOPPFrail criteria, while defined as inadequate for moderate severe pain. Logistic regression analysis identified PPOs. observed 40.2% higher those over 70 years old (48.7%) multiple comorbidities. Statins (25.5%) antihypertensives (29.4%) most common PIMs. Among pain, 45.5% experienced due prescriptions. Older age (OR 3.90, p < 0.01) comorbidities 20.90, significantly PIMs, diabetes was linked 2.00, = 0.01). The findings highlight critical gaps medication patients. Systematic deprescribing protocols improved strategies address stigma hesitancy essential align treatments goals enhance patient

Language: Английский

Citations

0
Awareness, perspectives and practices of antibiotics deprescribing among physicians in Jordan: a cross-sectional study DOI Creative Commons
Rana Abu Farha, Lobna Gharaibeh, Karem H. Alzoubi

et al.

Journal of Pharmaceutical Policy and Practice, Journal Year: 2024, Volume and Issue: 17(1)

Published: July 19, 2024

Background: Antibiotics have significantly reduced mortality and improved outcomes across various medical fields; however, the rise of antibiotic resistance poses a major challenge, causing millions deaths annually. Deprescribing, process that involves discontinuing unnecessary antibiotics, is crucial for combating this threat. This study was designed to assess knowledge, perceptions, practices physicians regarding deprescribing in Jordan.

Language: Английский

Citations

1
Use of the Patient Portal to Discuss Medications Among People with Dementia and Their Care Partners DOI
Ariel R. Green, Aleksandra Wec, Kelly T. Gleason

et al.

Journal of General Internal Medicine, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Citations

1
Considerations, barriers and enablers of deprescribing among healthcare professionals in Ogun State, Southwest, Nigeria: a cross-sectional survey DOI Creative Commons
Sule A. Saka,

Tolulope Ruth Osineye

BMC Health Services Research, Journal Year: 2024, Volume and Issue: 24(1)

Published: May 24, 2024

Abstract Background Deprescribing is a clinical intervention aimed at managing polypharmacy and improving older adults’ health outcomes. However, evidence suggests that healthcare professionals (HCPs) may face challenges in implementing the intervention. This study to explore considerations, barriers enablers of deprescribing among HCPs Southwest Nigeria. Methods A quantitative cross-sectional survey was carried out consecutively sampled including physicians, pharmacists nurses two public tertiary hospitals Ogun State, Southwest, structured 43-item self-administered questionnaire used participants’ sociodemographics, HCPs’ experience, adults. The data were summarised using descriptive statistics frequency percentage. Kruskal–Wallis test determine differences perceptions groups on Likert scale. p -value < 0.05 considered significant. Results Overall, 453 copies analysed. Of participants 204 (45.0%) within age group 20–30 years; 173 (38.2%) claimed adults occasionally requested their medications. majority (417; 92.1%) patients’ quality life be very important deprescribing; 423 (93.4%) opined having care goal known members HCP team an enabler for while 308 (68.0%) disagreed or strongly lack incentives remuneration de-prescribe barrier deprescribing. There significant difference across professional assertion pressure from pharmaceutical companies ( = 0.037). Conclusions this had various considerations medication life. Having every involved patient not necessarily need regulations policies support identified reduce effective process.

Language: Английский

Citations

0